REG - Wise PLC - Total Voting Rights

RNS Number : 5202N Wise PLC 02 January 2026 Wise plc(the "Company")Total Voting Rights and CapitalIn accordance with Disclosure Guidance and Transparency Rule 5.6.1 the Company would like to notify the market of the following:The Company's issued share capital consists of 1,025,672,252 class A ordinary shares of £0.01, each carrying one vote ("Class A Shares") and 214,084,255 class B ordinary shares of £0.000000001. The Company does not hold any Class A Shares or Class B Shares in treasury.The total number of voting rights attributable to the Class A Shares is 1,025,672,252.The total number of voting rights attributable to the Class B Shares is 1,926,758,295 and therefore the total number of voting rights in the Company in aggregate across the Class A Shares and the Class B Shares is 2,952,430,547.It is noted that the latest aggregate voting rights in the Company across the Class A Shares and the Class B Shares would result in Kristo Käärmann holding over 50% of the total voting rights in the Company through his Class A Share and Class B Share holding. In accordance with the Company's articles of association, for so long as Kristo Käärmann remains Chief Executive Officer of the Company, his voting rights are capped by reducing the exercisable votes in respect of his Class B Share holding to one vote below 50% of the total votes eligible to be cast in respect of a shareholder resolution (reducing to one vote below 35% should he cease to be Chief Executive Officer of the Company).When accounting for the total number of Class B Share voting rights that will be restricted as a result of the above mentioned cap, the total exercisable voting rights in the Company in aggregate across the Class A Shares and Class B Shares is 2,618,702,175.For any queries related to this, please contact the Company Secretariat on cosec@wise.comThis information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END TVRGZGGMFZLGVZM